Stocks and Investing
by (remove) : Robert Driscoll
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Robert Driscoll
RSSJSONXMLCSV
Tue, October 8, 2024
Fri, September 20, 2024
Tue, September 10, 2024
Tue, August 13, 2024
Mon, August 12, 2024
Thu, August 8, 2024
Wed, August 7, 2024
Wed, July 31, 2024
Wed, July 3, 2024
Thu, May 23, 2024
Fri, May 10, 2024
Wed, May 8, 2024
Tue, April 23, 2024
Mon, April 8, 2024
Wed, March 27, 2024
Thu, March 21, 2024
Wed, March 20, 2024
Wed, March 13, 2024
Wed, February 28, 2024
Fri, December 29, 2023
Thu, November 9, 2023
Wed, November 8, 2023
Mon, October 23, 2023
Tue, September 12, 2023
Fri, August 11, 2023
Thu, August 10, 2023
Fri, June 30, 2023

Robert Driscoll Reiterated (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024


Published on 2024-10-28 14:41:59 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Reiterated "Black Diamond Therapeutics, Inc." (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024.

Robert has made no other calls on BDTX in the last 4 months.



There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Tuesday, September 24th, 2024
  • Joseph Catanzaro of "Piper Sandler" Maintained at Buy with Increased Target to $15 on, Monday, September 23rd, 2024
  • Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024
Contributing Sources